Clinical Trial

Photo-experiencing and Reflective Listening (PEARL) to Promote Healing Engagement for Survivors of Violence

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 23, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn if a photo-elicitation intervention called PEARL (Photo-experiencing and Reflective Listening) can promote healing engagement in survivors of interpersonal violence. It will also learn about the feasibility and acceptability of PEARL. The main questions it aims to answer are: Does PEARL reduce barriers to help-seeking for trauma? Does PEARL improve trauma coping self-efficacy? Does PEARL change post-trauma cognitions and readiness for recovery? Is PEARL feasible and acceptable to survivors of interpersonal violence? Researchers will compare people who receive PEARL immediately to people on a waitlist (who receive PEARL three months later) to see if PEARL improves healing engagement and help-seeking behaviors. Participants will: * Complete baseline surveys about their trauma history, mental health, healing, and help-seeking behaviors * Be randomly assigned to receive PEARL immediately or after a 3-month wait * Receive a photography-focusing prompt and create photos over two weeks (those in the immediate group or after the waiting period) * Participate in a reflective listening interview about their photos * Complete follow-up surveys immediately after the intervention and one month later * Participate in a one-month follow-up interview about their experience
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-01.
Trial Details
NCT Number NCT07277816
Lead Sponsor Temple University
Collaborators: National Institute of Nursing Research (NINR)
Conditions Violence and Victimization
Enrollment 40 participants
Start Date 2025-12-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-23